Emmessar Biotech & Nutrition Ltd - Stock Valuation and Financial Performance

BSE: 524768 | NSE: | Pharmaceuticals & Drugs | Small Cap

Emmessar Biotech&Nut Share Price

29.85 0.59 2.02%
as on 28-Mar'24 16:01

DeciZen - make an informed investing decision on Emmessar Biotech&Nut

M-Cap below 100cr DeciZen not available

Emmessar Biotech & Nutrition stock performance -

mw4me loader
P/E Ratio (SA):
25.78
Market Cap:
14.9 Cr.
52-wk low:
21.1
52-wk high:
47.7

Is Emmessar Biotech & Nutrition Ltd an attractive stock to invest in?

1. Is Emmessar Biotech & Nutrition Ltd a good quality company?

Past 10 year's financial track record analysis by Moneyworks4me indicates that Emmessar Biotech & Nutrition Ltd is a good quality company.

2. Is Emmessar Biotech & Nutrition Ltd undervalued or overvalued?

The key valuation ratios of Emmessar Biotech & Nutrition Ltd's currently when compared to its past seem to suggest it is in the Fair zone.

3. Is Emmessar Biotech & Nutrition Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Emmessar Biotech & Nutrition Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Emmessar Biotech&Nut:

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Emmessar Biotech & Nutrition Ltd has performed well in majority of the past ten years indicating its past ten year financial track record is very good

Value Creation

Value Creation Index Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
ROCE % -17%-8%15.7%79.1%36.1%22.4%23.9%29.1%5%7.8%-
Value Creation
Index
-2.2-1.60.14.71.60.60.71.1-0.6-0.5-

Growth Parameters

Growth Parameters Colour Code Guide

Sales 1.42.222.61.30.63.470.411
Sales YoY Gr.-59.9%-10.1%33.5%-52.5%-49.6%439.7%105.6%-94.9%183.3%-
Adj EPS -0.6-0.20.42.41.81.51.92.90.611.2
YoY Gr.-NANA555.6%-22.5%-19.7%27.9%54.3%-79.7%69.5%-
BVPS (₹) 3.22.81.84.2678.511.412.413.314.1
Adj Net
Profit
-0.3-0.10.21.20.90.70.91.50.30.51
Cash Flow from Ops. 000.40.80.70.410.52.30.4-
Debt/CF from Ops. 000000.20000.2-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales -3.2%-4%-33.1%183.3%
Adj EPS NA-11.4%-19%69.5%
BVPS17.4%17.5%16.1%8%
Share Price 21.1% 10.8% 27.2% 19.8%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23TTM
Return on
Equity %
-17.1-8.115.678.63622.624.129.157.88.4
Op. Profit
Mgn %
-3.9-6.50.68.6-33.3-101.6-11.912.1-242.5-67.1-106.4
Net Profit
Mgn %
-22-5.5944.872.9116.527.620.780.949.271.9
Debt to
Equity
0000000000-
Working Cap
Days
4771261751523339051931242,0443262,116
Cash Conv.
Cycle
766364403918747571,347381,984

Recent Performance Summary

No data to display

Return on Equity has declined versus last 3 years average to 8.40%

Sales growth has been subdued in last 3 years -33.06%

Net Profit has been subdued in last 3 years -18.98%

Sales growth is not so good in last 4 quarters at 9.42%

Latest Financials - Emmessar Biotech & Nutrition Ltd.

Standalone Consolidated
TTM EPS (₹) 1.2 -
TTM Sales (₹ Cr.) 0.8 -
BVPS (₹.) 14.1 -
Reserves (₹ Cr.) 2 -
P/BV 2.11 -
PE 25.78 -
From the Market
52 Week Low / High (₹) 21.10 / 47.69
All Time Low / High (₹) 1.00 / 55.65
Market Cap (₹ Cr.) 14.9
Equity (₹ Cr.) 5
Face Value (₹) 10
Industry PE 48.2

Management X-Ray of Emmessar Biotech&Nut:

Shareholding Pattern

Promoter's Holding & Share Pledging

Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Event Update

Login/Register to view analysis.

Analyst's Notes

Key Ratios of Emmessar Biotech&Nut

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Sales1.372.191.972.631.250.633.406.990.361.02
Operating Expenses 1.432.331.962.411.671.273.806.141.261.71
Manufacturing Costs0.410.930.410.730.390.251.371.630.040.05
Material Costs0.460.8010.980.630.121.543.530.130.40
Employee Cost 0.230.280.310.390.410.580.580.640.770.84
Other Costs 0.340.320.240.310.240.320.310.340.320.42
Operating Profit -0.06-0.140.010.23-0.42-0.64-0.400.85-0.89-0.69
Operating Profit Margin (%) -4.5%-6.6%0.6%8.6%-33.3%-101.0%-11.9%12.1%-245.0%-67.6%
Other Income 0.090.060.260.981.271.301.471.471.921.75
Interest 0000.01000000
Depreciation 0.200.070.030.010.050.080.060.060.090.09
Exceptional Items 00-0.9200-0.29-0.26000
Profit Before Tax -0.17-0.16-0.681.180.800.290.742.250.930.97
Tax 0.14-0.04-0.210-0.12-0.24-0.020.800.460.46
Profit After Tax -0.31-0.12-0.471.180.910.530.751.450.480.50
PAT Margin (%) -22.4%-5.4%-23.6%44.8%72.9%84.7%22.2%20.7%130.3%49.4%
Adjusted EPS (₹)-0.6-0.2-0.92.41.81.11.52.91.01.0
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23

Equity and Liabilities

Shareholders Fund 1.581.370.912.092.983.514.265.706.176.66
Share Capital 5555555555
Reserves -3.42-3.62-4.09-2.91-2.01-1.49-0.730.701.171.67
Minority Interest0000000000
Debt000000.070000.08
Long Term Debt0000000000
Short Term Debt000000.070000.08
Trade Payables0.150.310.200.200.010.580.800.500.020
Others Liabilities 0.490.741.050.810.690.530.351.291.411.35
Total Liabilities 2.222.422.163.113.684.685.417.497.608.09

Fixed Assets

Gross Block3.113.111.311.302.882.632.602.602.022.04
Accumulated Depreciation1.531.680.580.580.630.640.680.740.560.65
Net Fixed Assets1.581.420.730.722.251.991.911.861.461.40
CWIP 0000.80000000
Investments 0.010.010.010.010.010.010.010.010.010.01
Inventories0.330.690.360.320.090.731.150.070.070.14
Trade Receivables0.170.040.360.040.030.040.032.710.010.01
Cash Equivalents 0.030.020.430.320.270.711.882.474.585.19
Others Assets0.110.240.270.891.031.210.440.381.471.35
Total Assets 2.222.422.163.113.684.685.417.497.608.09

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Cash Flow From Operating Activity 0-0.010.440.750.740.391.030.472.270.38
PBT -0.17-0.16-0.681.180.800.5812.250.930.97
Adjustment 0.190.070.730.060.01-0.07-0.31-0.07-0.13-0.15
Changes in Working Capital -0.020.080.39-0.45-0.02-0.120.34-1.611.76-0.5
Tax Paid 000-0.04-0.0500-0.10-0.290.06
Cash Flow From Investing Activity 00-0.46-0.74-0.69-0.37-1.060.01-2.61-0.55
Capex 00-0.02-0.01-0.78000-0.31-0.03
Net Investments 00000.08-0.41-1.19-0.11-2.45-0.78
Others 00-0.44-0.740.010.040.140.120.140.26
Cash Flow From Financing Activity 0000000000
Net Proceeds from Shares 0000000000
Net Proceeds from Borrowing 0000000000
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow 0-0.01-0.020.010.050.01-0.030.48-0.34-0.17
PARTICULARSMar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23
Ratios
ROE (%)-17.71-7.98-40.7578.733616.4219.429.18.017.85
ROCE (%)-9.52-10.49-59.3779.4631.46918.8745.2915.7114.99
Asset Turnover Ratio0.390.980.891.030.390.150.671.080.050.13
PAT to CFO Conversion(x)N/AN/AN/A0.640.810.741.370.324.730.76
Working Capital Days
Receivable Days37217362710213711,3624
Inventory Days8182934656236101326837
Payable Days1,190105937661857163677530

Emmessar Biotech & Nutrition Ltd Stock News

Emmessar Biotech & Nutrition Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Emmessar Biotech&Nut on 28-Mar-2024 16:01 is ₹29.85.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 28-Mar-2024 16:01 the market cap of Emmessar Biotech&Nut stood at ₹14.85.
The latest P/E ratio of Emmessar Biotech&Nut as of 28-Mar-2024 16:01 is 25.78.
The latest P/B ratio of Emmessar Biotech&Nut as of 28-Mar-2024 16:01 is 2.11.
The 52-week high of Emmessar Biotech&Nut is ₹47.69 and the 52-week low is ₹21.10.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Emmessar Biotech&Nut is ₹0.80 ( Cr.) .

About Emmessar Biotech & Nutrition Ltd

Emmessar Biotech & Nutrition Ltd., was originally started as Emmessar Chemical Industries Ltd on  March 17,1992, for manufacturing Super Speciality Fine Chemicals. The Company succeeded in developing many Speciality Fine Chemicals in its own In-house R&D, which was recognised on  January 15, 1996 by DSIR, Ministry of Science & Technology, Government of India, New Delhi .

When there was a realisation that some of the Speciality Chemicals developed in our R&D and exported to USA & Europe were being used in Healthcare formulations, the Company decided to re-orient itself and enter the Healthcare business, which is poised for phenomenal growth in the coming decades.

Concurrently the company also realised that some of the Speciality Chemicals are actually Vital Micro Nutrients, which are being used in the research worldwide as tools of Biotechnology, the Company took a conscious decision to enter the field of Biotechnology & Healthcare.

To ensure that the name is representative of its activity, the company's name was changed from Emmessar Chemical Industries Ltd., to Emmessar Biotech & Nutrition Ltd., on 7th April 2000.

In the process of pursuing its own R&D and exploring commercial market potentials for their products in the field of Healthcare, the company came across another reputed company in USA Vibrant Life in California.

Intense exchange of ideas & technical information between Emmessar Biotech & Nutrition Ltd., & Vibrant Life, resulted in development of several new concepts and new technologies - combining different schools of thought such as Nutraceuticals, Cosmeceuticals, Ayurveda & Biotechnology.

The company has developed many products covering different areas of healthcare that include obstinate Skin problems & debilitating chronic physical ailments.

Emmessar Biotech & Nutrition Ltd., is a Public Limited Company, with the Paid-up Share Capital of about Rs. 50.00 million (over $ 1.00 million). The Stocks of Emmessar Biotech & Nutrition Ltd., are traded in The Bombay Stock Exchange Ltd.

Product range of the company includes:

Present products

  • Calmcream 
  • Magicream 
  • Supportt Joint  
  • Supportt Bones
  • Micro Nutrients 
  • Speciality Chemicals
  • CC-99  
  • Biosulf  
  • Calmcream  

Products planned to be launched in future

  • Ayurvedic Creams  
  • Nutraceutical Creams
  • Cosmeceutical Creams  
  • Oral Supplements  
Read More Read Less
You have 2 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2024 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt.Ltd.